1. Home
  2. FENC vs PMX Comparison

FENC vs PMX Comparison

Compare FENC & PMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FENC
  • PMX
  • Stock Information
  • Founded
  • FENC 1996
  • PMX 2002
  • Country
  • FENC United States
  • PMX United States
  • Employees
  • FENC N/A
  • PMX N/A
  • Industry
  • FENC Biotechnology: Biological Products (No Diagnostic Substances)
  • PMX Trusts Except Educational Religious and Charitable
  • Sector
  • FENC Health Care
  • PMX Finance
  • Exchange
  • FENC Nasdaq
  • PMX Nasdaq
  • Market Cap
  • FENC 229.8M
  • PMX 233.7M
  • IPO Year
  • FENC 2001
  • PMX N/A
  • Fundamental
  • Price
  • FENC $7.76
  • PMX $6.76
  • Analyst Decision
  • FENC Strong Buy
  • PMX
  • Analyst Count
  • FENC 2
  • PMX 0
  • Target Price
  • FENC $13.00
  • PMX N/A
  • AVG Volume (30 Days)
  • FENC 86.3K
  • PMX 101.5K
  • Earning Date
  • FENC 08-12-2025
  • PMX 01-01-0001
  • Dividend Yield
  • FENC N/A
  • PMX 5.28%
  • EPS Growth
  • FENC N/A
  • PMX N/A
  • EPS
  • FENC N/A
  • PMX N/A
  • Revenue
  • FENC $30,912,000.00
  • PMX N/A
  • Revenue This Year
  • FENC $0.85
  • PMX N/A
  • Revenue Next Year
  • FENC $55.16
  • PMX N/A
  • P/E Ratio
  • FENC N/A
  • PMX N/A
  • Revenue Growth
  • FENC N/A
  • PMX N/A
  • 52 Week Low
  • FENC $3.96
  • PMX $6.09
  • 52 Week High
  • FENC $8.72
  • PMX $8.47
  • Technical
  • Relative Strength Index (RSI)
  • FENC 51.69
  • PMX 44.26
  • Support Level
  • FENC $7.53
  • PMX $6.75
  • Resistance Level
  • FENC $8.19
  • PMX $6.83
  • Average True Range (ATR)
  • FENC 0.47
  • PMX 0.07
  • MACD
  • FENC -0.12
  • PMX 0.00
  • Stochastic Oscillator
  • FENC 19.67
  • PMX 30.77

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

About PMX PIMCO Municipal Income Fund III of Beneficial Interest

PIMCO Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as transportation, healthcare, and others.

Share on Social Networks: